[Contemporary alternatives in the diagnostics and therapy of female androgenetic alopecia].

Cas Lek Cesk

Kozní oddilení--Masarykova nemocnice, Ustí nad Labem.

Published: May 2006

Female androgenetic alopecia belongs to the family of scar-less, diffuse, telogenic, hormonally determined alopecias with hereditary disposition. In the androgenetic alopecia, progressive, androgen mediated miniaturization of genetically predestined hair follicles develops. Genetic factors play a role namely in females without the higher serum androgen level. Pathologically high level of serum androgens is usually accompanied with signs of virilization. Hair dropping starts in the fourth decade or earlier. It occurs in the postmenopausal period, after a pregnancy, after the onset or termination of peroral contraception, in women treated by aromatase inhibitors.

Download full-text PDF

Source

Publication Analysis

Top Keywords

female androgenetic
8
androgenetic alopecia
8
[contemporary alternatives
4
alternatives diagnostics
4
diagnostics therapy
4
therapy female
4
androgenetic alopecia]
4
alopecia] female
4
alopecia belongs
4
belongs family
4

Similar Publications

Background: Seborrheic dermatitis (SD) is a chronic, inflammatory disease characterized by unknown etiopathogenesis. It affects skin areas rich in sebaceous glands. There are strong data on the relationship between nutrition habits, body mass index (BMI), psychoemotional status, and sebaceous gland diseases such as acne, rosacea, and androgenetic alopecia.

View Article and Find Full Text PDF

Nowadays androgenetic alopecia (AGA) has become a common concern of affected subjects of both sexes. Finasteride is approved by the Food and Drug Administration for the treatment of male AGA. There is no clear evidence to support the use of dutasteride in male AGA.

View Article and Find Full Text PDF

Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies.

Int J Nanomedicine

December 2024

School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China.

Introduction: Alopecia is a systemic disease with multiple contributing factors. Effective treatment is challenging when only hair growth mechanisms are targeted while ignoring the role of maintaining hair follicle microenvironment homeostasis, which is crucial for cell growth and angiogenesis. Oxidative stress and inflammation are major disruptors of this microenvironment, leading to inhibited cell proliferation and compromised hair follicle circulation.

View Article and Find Full Text PDF

With the widespread prevalence of COVID-19, researches have suggested a potential link between androgens and COVID-19 outcomes. However, the relationship between COVID-19 and androgenetic alopecia (AGA)-a condition strongly influenced by androgens-remains controversial in existing studies. Notably, there is a lack of large-scale clinical studies, particularly concerning data on the Chinese population following infection with the Omicron variant.

View Article and Find Full Text PDF

Background & Objective: FFA usually has a gradual subtle course and might be overlooked by physicians or misdiagnosed with other types of hair loss including androgenetic alopecia, traction alopecia, and other types of patterned alopecia. In this study, we described clinicopathological features of patients with FFA referring for skin biopsy.

Methods: This is a retrospective cross-sectional study on 26 patients with a diagnosis of FFA based on clinicopathological features.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!